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Abstract

Intrauterine exposure to nicotine is one of the largest modifiable risk factors for infant
morbidity and mortality. Previous progress toward decreasing the number impacted by
intrauterine nicotine exposure has recently plateaued. While guidelines for assisting pregnant
women to stop smoking are available, few providers have a formalized protocol in place. This
project will evaluate most current research evidence regarding smoking cessation during
pregnancy in order to develop a formalized protocol for implementation in an obstetric clinic in
Southwest Ohio. Reviewed literature was summarized and level of evidence was established.
Recommendations were made and categorized as strong, moderate, and weak. The information
was compiled into a formalized protocol with hand outs and disseminated to select obstetric
providers in Southwest Ohio.
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Smoking Cessation during Pregnancy: An Evidence Based Practice Protocol
Chapter 1: Introduction
Background
Smoking during pregnancy is one of the largest modifiable risk factors for infant
morbidity and mortality (Smoking cessation during pregnancy, 2011; Tong et al, 2013). Rates of
smoking during pregnancy have decreased due to public health education and campaigns within
the United States (ACOG, 2010). However, rates have plateaued over recent years. In 2010,
only 10.7 percent of women smoked during pregnancy (Tong et al, 2013) compared to nearly 42
percent in 1990 across the United States (ACOG, 2010). Many of these women also work hard to
quit smoking during pregnancy. The Morbidity and Mortality Weekly Report published by the
Center for Disease Control and Prevention (CDC) shows approximately 55 percent of U.S.
pregnant smokers quit during pregnancy (Tong et al, 2013), however approximately 40 percent
relapse within six months postpartum (Tobacco use and pregnancy, 2014; Tong et al, 2013).
Within Ohio, 47.2 percent of pregnant smokers quit smoking during pregnancy in 2010, with 22
percent relapsing back to smoking after delivery (Tong et al, 2013). Both of these statistics show
that a large number of women and babies are affected by smoking during pregnancy. Within
Ohio, 16.5 – 21.6 percent of pregnant women smoked within the third trimester between 2000
and 2010 (Tong et al, 2013). The lowest percentage, 16.5 percent occurred in 2010. However,
just one year prior 21 percent of pregnant women smoked during pregnancy. The second lowest
year occurred in 2000 at 17.1 percent (Tong et al, 2013). These statistics show that the rates in
smoking cessation during pregnancy have plateaued in recent years. Therefore, the current
methods of assisting pregnant patients to stop smoking are not affective.
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Significance
Smoking during pregnancy can cause unwanted effects to mother and fetus. During
pregnancy, smoking causes decreased placental size and blood flow (Anblogan et al, 2013)
which can cause placenta previa, abruptio placenta, and premature rupture of membranes (Castle
et al, 1999; Shiozaki et al, 2011; Youngkin & Davis, 2013). Smoking any amount of cigarettes
during pregnancy can lead to small for gestational age babies with decreases in birth weight,
length, and head circumference (Batech et al, 2013; Gunnerbeck et al, 2011; Pickett et al, 2009;
Roza, 2007; Ward, Lewis, & Coleman, 2007). Babies born to smoking mothers have an
increased risk of low birth weight and preterm birth not only when compared to births of nonsmoking mothers, but they are also at significantly increased risk when compared to babies born
to mothers who quit smoking during pregnancy (Batech et al, 2013). Decreased organ size
including brain, kidneys, and lungs in babies exposed to nicotine in utero has also been observed
(Anblogan et al, 2013). These growing issues can continue after delivery as well. The newborn
who was exposed to nicotine in utero continues to grow at decreased rates during through
puberty (Fogelman & Manor, 1988). After delivery, newborns who were exposed to tobacco in
utero suffered significantly more apnea episodes (Gunnerbeck et al, 2011). Adolescents born to
mothers who smoked during pregnancy are more likely to have asthma (Shripak, 2014). As
described above, smoking during pregnancy decreases health of baby and can negatively affect
growth and development which leads to increased morbidity and mortality for infants exposed to
smoke in utero.
Problem
Even with clear research evidence showing the damaging effects of smoking during
pregnancy, many women’s health providers lack an evidence based practice protocol to address
2

this issue. Oak Creek Ob/Gyn currently does not have a formal protocol in place. Among their
practitioners, all survey respondents reported advising their smoking pregnant patients to quit.
Half of the respondents reported following ACOG guidelines and half reported not following any
set guidelines (K.R. Ruhlman, personal communication, November, 2014). In Ohio, nearly all
providers recognize the damaging effects of smoking and ask their pregnant patients about
smoking (Jordan et al, 2006). However, after the initial inquiry, many do not assist their patients
in taking steps to quit. The American College of Obstetrics and Gynecology (ACOG, 2010) has
outlined a five step program for women’s health practitioners to assist their patients with
smoking cessation. However, only six percent of Ohio obstetric providers actually use this
protocol to its full extent (Jordan et at, 2006). Looking outside of Ohio this trend continues. Dr.
Chang and associates (2013) monitored obstetrics offices within the United States for
implementation of the smoking cessation program suggested by ACOG at first antepartum visits.
Within their study no practitioners ever used all five of the steps recommended by ACOG and
only 21 percent used three or more of the steps at the first antepartum visit (Chang et al, 2013).
Studies show obstetric providers do not feel adequately prepared to successfully assist their
patients to stop smoking early in pregnancy (Kim et al, 2009). This lack in preparation can be
due to inadequate education, lack of appropriate resources, or time constraints. Without a quick
and easy to use tool with clinic based interventions available at providers’ finger tips, rates in
smoking cessation are unlikely to change (Kim et al, 2009).
Purpose
Therefore, the purpose of this project is to evaluate research on smoking cessation during
pregnancy and develop a quick, easy to use, evidence based practice protocol for implementation
at Oak Creek OB/Gyn in southwest Ohio.
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Chapter 2: Concept Analysis
In this section, the concept of smoking cessation assistance during pregnancy will be
analyzed and operationally defined. The established operational definition for smoking cessation
during pregnancy will help guide research on this topic and the development of an evidence
based practice protocol.
Use of the Concept
The concept of smoking cessation assistance is a nursing intervention from the Nursing
Intervention Classification (Mosby’s dictionary of medicine, nursing, & health professions,
2006) and is defined as “helping a patient stop smoking through individual or group process”
(Bluecheck, 2013). However, smoking cessation assistance during pregnancy is a combined term
and is not formally defined in literature. For this reason, this concept will be broken down into
defining attributes.
Defining Attributes
Smoking cessation assistance during pregnancy is made up of three defining attributes
including 1) current smoker, 2) attempting to stop smoking, and 3) pregnancy.
Current smoker. Among current literature smoking status can be evaluated two ways
including self-report (MMWR, 2011; Salmond et al, 2012; Dzubur, 2013; Patient Protection and
Affordable Care Act, 2010) or biomedical testing (Melvin & Tucker, 2000). The CDC’s National
Health Interview Survey (2009) used a self-report questionnaire to categorize interviewed US
citizens as current smokers, former smokers, or never smoked. Those interviewed were asked,
“Have you smoked at least 100 cigarettes in your entire life? (NHIS, 2009)” Those who
answered, “yes” were asked, “Do you now smoke cigarettes every day, some days, or not at all?
(NHIS, 2009)” Those who answered every day were considered current smokers while those
4

who answered “some days” were considered current smokers attempting to quit. Salmond and
associates (2012) also asked interviewees to self-report smoking status by answering the
question, “Do you smoke regularly (that is one or more cigarettes a day)? (Salmond et al, 2012,
p. 665)” Melvin and Tucker (2000) used the same question proposed by the CDC, however they
also suggested verifying these answers via biochemical testing including cotinine levels in urine
or saliva or verify by measuring expired carbon monoxide. Cotinine is the main metabolite of
nicotine and stays in the body significantly longer than nicotine (Cotinine, 2013). Because of
this, cotinine levels are the gold standard for biochemically verifying smoking status (Cotinine,
2013). Melvin and Tucker (2000) further clarify the CDC’s second question by asking whether
the interviewee has smoked at least once in the last seven days. Those who have smoked even a
puff in the last seven days are considered current smokers. The Patient Protection and Affordable
Care Act (2010) defines current smokers as those who have smoked four or more times in a
week within the previous six months. For the sake of this project, a current smoker is someone
who self-reports smoking 100 cigarettes in their life and has smoked at least once in the last
seven days.
Smoking cessation. Cessation of smoking means to temporarily or permanently stop
smoking (Merriam-Webster, n.d.). Building off of the above definition of smoking, someone
who has stopped smoking must not meet the definition of current smoker. Therefore they must
have not smoked even once in the last seven days. Within currently literature there are two main
ways to measure smoking cessation including 24 hour self-report (Catley et al, 2012; Etter 2009;
Whitwell, 2011) or 7 days reported or verified smoke free (Catley et al, 2012; Chan et al, 2012;
Winickoff et al, 2010) . Some studies use both of these measures with a higher percentage
reporting smoke free for 24 hours compared to 7 days (Mason, Gilbert, & Sutton, 2012; Lycet,
5

Hajek, & Aveyard, 2010). One study suggested that any self-reported quit attempt, even less
than 24 hours should be included in the definition of smoking cessation (Hughes et al, 2010). In
non-pregnant adults, the reason for smoking cessation assistance is to recognize quit attempts in
order to aid the patient in moving along stages of change to ultimately reach sustained cessation
(Cabezas et al, 2011; Chan et al, 2012; Kim et al, 2013; Prochaska & Velicer, 1997). However,
no amount of nicotine is safe in pregnancy and one puff can cause some extent of harm to the
fetus (ACOG, 2010). Because of this effect, the premise for recognizing cessation attempts is to
minimize or eliminate nicotine exposure to the fetus. Therefore, a full seven day cessation is
used to define smoking cessation in pregnancy. For the purpose of this paper, smoking cessation
means the patient has not taken even one puff of a cigarette in the previous seven days.
Pregnancy. Barnhart and associates (2010) published a review of literature for pregnancy
definitions. They established formal operational definitions for intrauterine pregnancies, ectopic
pregnancies, and pregnancies of undefined location. Since smoking cessation during pregnancy
focuses on improving outcomes for both mother and unborn child, intrauterine pregnancies are of
most interest. Barnhart and his associates (2010) define pregnancy based on transvaginal
ultrasound. They identify intrauterine pregnancies as “intrauterine gestational sac with yolk sac
and/or embryo (with or without cardiac activity). (Barhart et al, 2010, p 859)” While transvaginal
ultrasound is the most sensitive way of positively diagnosing intrauterine pregnancy (Murray &
McKinney, 2010; Youngkin & Davis, 2013), most uncomplicated pregnancies only receive an
ultrasound at 18-22 weeks gestation (ACOG, 2013; Group health, 2013; United healthcare, n.d.;
Youngkin et al, 2013). American College of Obstetricians and Gynecologists (ACOG,2013) calls
for urine β-hcg level measurement to initially confirm pregnancy. Based off this standard
established by ACOG, insurance companies will only pay for an ultrasound between 18-22
6

weeks unless signs of complications present prior (ACOG, 2013; Group health, 2013; Unite
healthcare, n.d.). Another positive sign of pregnancy is auscultation of fetal heart tones through
the abdomen (Murray & McKinney 2010; Youngkin et al, 2013). Fetal heart tones can initially
be heard between eight and twelve weeks gestation (Murray & McKinney, 2010; Youngkin et al,
2013). Many women present to the clinic for pregnancy confirmation earlier than eight weeks.
ACOG guidelines recommend always confirming pregnancy with urine β-hcg in the office
setting and if beyond 8 weeks of gestation, auscultate fetal heart tones (ACOG, 2013). Since the
standard care in the United States is to verify pregnancy only by positive urine β-hcg at initial
conception visit (ACOG, 2013; Youngkin, et al, 2013; Group health, 2013; United healthcare,
n.d.), this is the definition that will be used in this paper. Therefore pregnancy is defined a
positive urine β-hcg test confirmed in a healthcare setting.
Theoretical Definition
Combining the above definitions, smoking cessation during pregnancy occurs when a
patient who has a healthcare confirmed positive urine β-hcg and was a current smoker at
conception who self-reported smoking 100 cigarettes in their life and had smoked at least once in
the seven days prior to conception, has not taken even one puff of a cigarette in the previous
seven days.
Chapter 3: Methods and Framework
Iowa Model
Theories and models within nursing provide a framework for conducting research and
developing evidence based protocols. The Iowa Model was developed in 1994 by Marita Titler
as a model to guide evaluation of current nursing practices as well as develop and implement
new practices grounded in best evidence (Titler, Kleiber, & Steelman, 2001). Since its
7

introduction, the Iowa Model has been utilized across the country to successfully guide
development of evidence based practice standards and protocols (Bergstrom, 2011; Haxton,
Doering, Gingras, & Kelly, 2012; Hermes, Deakin, Lee, & Robinson, 2009; Kowal, 2010). This
project will follow the Iowa Model which has six steps: select a topic, form a team, retrieve
evidence, develop an evidence based practice protocol, implement the new practice, and finally
evaluate the outcome. However, this project is focused on developing an evidence based practice
protocol, thus will only be using steps one through four.
Select a topic. As discussed above, this project will analyze research on assisting patients
toward smoking cessation during pregnancy. The compilation of research will then be developed
into an evidence based practice protocol. The topic of smoking cessation during pregnancy is
explored and formally defined above.
Form a team. For this project a committee has been formed to guide research and
development of the protocol. Dr. Angelia Mickle will chair the project committee and focus on
overseeing and guiding project progression and implementation. Nurse Practitioner Carol Cooke
has agreed to sit on this project committee and act as a liaison between research synthesis and
practical implementation. She is a practitioner at Oak Creek OB/Gyn and will connect the
academic research process to implementation where she practices.
Evidence retrieval. Evidence retrieval will begin January 5th, 2015 and will conclude
February 8th, 2015. During this time Academic Search Complete, CINAHL, Cochrane,
Healthsource: Nursing/Academic, and Medline databases will all be searched using the terms
“smoking cessation” and “pregnancy” for articles published since 2009. Websites of applicable
governing agencies such as ACOG, American Academy of Pediatrics, and the CDC will also be
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searched for guidelines and research. Retrieved research will be stored and organized using
Mendeley reference manager.
Developing an evidence based practice protocol. An evidence based practice protocol
will be developed from the research and best evidence found during retrieval. This protocol will
be developed for implementation at Oak Creek Ob/Gyn. Oak Creek is a primary care women’s
health practice made up of three office locations in which ten providers practice including seven
Physicians and three Nurse Practitioners. Committee member Carol Cooke practices within this
group as a Nurse Practitioner and will help guide implementation. In order for implementation of
any new protocol it is vital that all participating members are on board and find value in the new
implementation. Therefore, the remaining nine practitioners in this group also are key players for
implementation of this protocol.
Chapter 4: Results
Databases and Key Terms
During the research process, five databases were searched as well as two governing
agencies. The databases included Academic Search Complete, CINAHL, Cochrane,
Healthsource: Nursing/Academic, and Medline. ACOG and the CDC online websites and
databases were searched as well. The search terms “smoking cessation” and “pregnancy” were
used and the search was limited to articles published since 2009.
Focus Areas
Inclusion criteria. Literature was searched for research regarding three main areas: (1)
understanding quitting and its barriers, (2) effects of quitting and cutting down, (3) ways to assist
the patient to stop smoking during pregnancy. Inclusion criteria were established using these
three focus areas. Assisting the patient to stop smoking during pregnancy was further divided
9

into three categories including behavioral intervention, nicotine replacement therapy, and
medications.
Exclusion criteria. Articles excluded from evaluation were articles evaluating relapse
post-partum, smoking with psychiatric disorders, and smoking with other drug addictions.
Anxiety and depression handled by primary care providers was not considered a psychiatric
disorder and was evaluated in this study. Some descriptive research articles included other drug
use as a descriptive variable while evaluating many variables. These studies were not specifically
evaluating drugs during pregnancy and were included in the evaluation of literature.
Findings
Research was grouped by above listed themes and formatted into a table for each
theme. Findings in each of these core areas were summarized for discussion in this section. Each
article was also summarized in tables below and level of evidence was identified. The level of
evidence rating system used seven levels with level one being the strongest made up of
systematic review (SR) of randomized controlled trials (RCT), level two includes articles from
atleast one RCT, level three includes controlled trials without randomization, level four includes
case control and cohort studies, level five includes SR of descriptive or qualitative studies, level
six is made up of descriptive or qualitative studies, and level seven is expert opinion. This rating
system has been used to develop nursing evidence based practice protocols and extensively in
nursing literature (Melnyk & Fineout-Overholt, 2005; Dearholt & Dang, 2012).
Understanding. After reviewing the literature, risk factors for smoking while pregnant
included age (Masho et al, 2013), less than a high school education (Masho et al, 2013; Alford,
Lappin, Peterson, & Johnson, 2009), unemployed, criminal history, social services involved,
ETOH and drugs (Masho et al, 2013), smoking partner, high rate of tobacco consumption,
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decreased or no pre-natal care, multiparous (Alford, Lappin, Peterson, & Johnson, 2009;
Schneider, Huy, Schultz, & Diehl, 2010). Risk factors for prohibiting smoking cessation while
pregnant were living with smoking partner, emotional distress (Hauge, Aarø, Torgersen, &
Vollrath, 2013) anxiety, depression, relationship discord, negative life events (Hauge, Torgerse,
& Vollrath, 2012; Massey & Compton, 2013), and stress (Haskins et al, 2010; Holtrop, Meghea,
Raffo, Biery, Chartkoff, & Roman, 2010), increased number of years between pregnancies
(Hauge, Aarø, Torgersen, & Vollrath, 2013), and heavy smoking/increased tobacco usage
(20+/d) (Hauge, Aarø, Torgersen, & Vollrath, 2013; Haskins et al, 2010). Barriers cessation
while pregnant included weight control, mood stabilization (Davies, 2012; Varescon, Leignel,
Poulain, & Gerard, 2011), and prenatal depression (Orr, Blazer, & Orr, 2012). Factors that play a
role in achieving cessation included being in an advanced stage of change due to pregnancy
(Buja et al, 2011). Table 1 summarizes the findings of each research article in this category.
Table 1: Understanding
Citation

Title

Level of
Evidence

Summary

1
U

(Flemming,
Graham,
Heirs, Fox,
& Sowden,
2013)

Smoking in Pregnancy: a
Systematic Review of
Qualitative Research of
Women who Commence
Pregnancy as Smokers

V

SR of
qualitative
research

Four main themes emerged regarding women’s experiences of
smoking during pregnancy. (1) Smoking was very embedded in
women’s lives. (2) Women felt like they were questioned about
smoking only because they were pregnant. (3) Many viewed
cessation as quitting for pregnancy rather than for good. (4)
Quitting had significant costs for the woman and cutting down
was a positive alternative.

2
U

(Hauge,
Aarø,
Torgersen,
& Vollrath,
2013)

Smoking During
Consecutive Pregnancies
among Primiparous
Women in the
Population-Based
Norwegian Mother and
Child Cohort Study

IV

cohort study

Risk factors preventing smoking cessation included living with
smoking partner, emotional distress, increased number of years
between pregnancies, heavy smoking

3
U

(Davies,
2012)

The Effect of Body
Image and Mood on
Smoking Cessation in
Women.

V

SR of
qualitative
and
quantitative
research

Many women use smoking as a way to control weight and
stabilize their mood.

11

4
U

(Buja et al,
2011)

Socio-Demographic
Factors and Processes
Associated with Stages
of Change for Smoking
Cessation in Pregnant
Versus Non-pregnant
Women.
Least Explored Factors
Associated with Prenatal
Smoking
Associations Between
Maternal Stress and
Smoking: Findings from
a Population-Based
Prospective Cohort
Study
A Preliminary
Examination of
Cognitive Factors that
Influence Interest in
Quitting During
Pregnancy

IV

descriptive
study

Pregnancy causes women to be at a more advanced stage of
change and thus more open to smoking cessation counseling.

5
U

(Masho et
al, 2013)

I
V

cohort study

IV

cohort study

Risk factors for smoking during pregnancy include age, less
than a high school education, unemployed, criminal history,
social services, alcohol or drug use.
Anxiety, depression, relationship discord, and negative life
events can decrease likelihood of smoking cessation.

6
U

(Hauge,
Torgerse,
& Vollrath,
2012)

7
U

(Ferguson
& Hansen,
2012)

VI

descriptive

Women are less likely to recognize risks to the fetus as a risk
of smoking compared to risks to other body systems.

8
U

(Schneider,
Huy,
Schultz, &
Diehl,
2010)
(Holtrop,
Meghea,
Raffo,
Biery,
Chartkoff,
& Roman,
2010)

Smoking Cessation
During Pregnancy: A
Systematic Literature
Review

II

SR of RCT

A smoking partner, a large number of children, a high rate of
tobacco consumption, as well as deficiencies in prenatal care
were predictors of smoking during pregnancy.

Smoking Among
Pregnant Women with
Medicaid Insurance: Are
Mental Health Factors
Related?

VI

descriptive

"Mental health history, stress, demographics, current alcohol
and past drug use are all strongly related to continued smoking
during pregnancy".

10
U

(Massey &
Compton,
2013)

Psychological
Differences Between
Smokers Who
Spontaneously Quit
During Pregnancy and
Those Who Do Not: A
Review of Observational
Studies and Directions
for Future Research

II

SR of RCT

Those with mental health histories are less likely to
spontaneously quit smoking during pregnancy.

11
U

(Alford,
Lappin,
Peterson, &
Johnson
2009)
(Varesco,
Leignel,
Poulain, &
Gerard,
2011)

Pregnancy Associated
Smoking Behavior and
Six Year Postpartum
Recall.

VI

descriptive

"Mother’s education, asthma status, amount of pre-pregnancy
smoking, gravidity, and father's smoking status were important
in the prediction of pregnancy associated smoking."

Coping Strategies and
Perceived Stress in
Pregnant Smokers
Seeking Help for
Cessation

IV

case control

Pregnant smokers attempting to quit report a higher level of
anxiety and lower coping strategies.

9
U

12
U

12

13
U

(Wigginton
& Lee,
2013)

14
U

(Tombor,
Urban,
Berkes, &
Demetrovic
s, 2010)
(Haskins et
al, 2010)

15
U

16
U

(Orr,
Blazer, &
Orr, 2012)

Stigma and Hostility
Towards Pregnant
Smokers: Does
Individuating
Information Reduce the
Effect?
Denial of SmokingRelated Risk among
Pregnant Smokers.

VI

descriptive

Perceptions of college students were more negative of smoking
mothers.

IV

cohort

A higher level of risk denial seems to be one of the major
determinants of women's smoking status during pregnancy.

Correlates of Smoking
Cessation at Pregnancy
onset among Hispanic
Women in
Massachusetts

IV

cohort

Maternal Prenatal
Depressive Symptoms,
Nicotine Addiction, and
Smoking-Related
Knowledge, Attitudes,
Beliefs, and Behaviors.

VI

descriptive

Women born outside the United States, a family history of
diabetes, and non-Puerto Rican Hispanics were more likely to
quit smoking. Women with high stress, marijuana use, and
parous women were less likely to quit. Women who smoked
20+ cigarettes/d in pre-pregnancy were less likely to quit
smoking compared with light smokers. Age, income, body
mass index, language preference, pre-pregnancy exercise, and
alcohol consumption were not associated with quitting.
Prenatal depressive symptoms may be a barrier to smoking
cessation.

(SR = systematic review; RCT = randomized controlled trial; U = category of understanding)
Effects of stopping and cutting down on smoking. Literature consistently reported
smoking cessation is the gold standard and first priority regarding tobacco exposure during
pregnancy. Smoking cessation reduces chance of low birth weight and prematurity (Flower,
Shawe, Stephenson, & Doyal, 2013). Cessation early in pregnancy is best. The literature supports
the third trimester as the cutoff point for benefit. Cessation prior to third trimester increases
weight, head circumference, and length (Bailey, McCook, Clements, & McGrady, 2011;
Vardavas, 2010). One of the only negative effects of smoking cessation during pregnancy is it
can cause pregnant women to gain more weight during pregnancy (Restall et al, 2014).
Reducing smoking as a secondary option for those who fail complete cessation during
pregnancy received mixed reviews. Reducing nicotine exposure during pregnancy can decrease
preterm delivery (Bailey, McCook, Hodge, & McGrady, 2012) and increases birth weight
(Flower, Shawe, Stephenson, & Doyal, 2013). However, Bengamin-Garner & Stotts (2013)
13

found although there was an increase in raw birth weight, differences were not statistically
significant. Consensus throughout all of these articles remains the same. Smoking cessation
should still be the gold standard. However, cutting down should be recognized as a second line
alternative measure (Graham, Flemming, Fox, Heirs, & Sowden, 2014). Table two summarizes
findings of each individual research article examining understanding quitting and cutting down.
Table 2: Effects of Quitting and Cutting Down
Citation

Title

17
E

(Amash &
Jaradeh,
2012)

18
E

(Flower,
Shawe,
Stephenson
, & Doyal,
2013)

19
E

20
E

(Bailey,
McCook,
Clements,
&
McGrady,
2011)
(Restall et
al, 2014)

21
E

(Vardavas,
2010)

22
E

(BengaminGarner &
Stotts,
2013)

23
E

(Bailey,
McCook,
Hodge, &
McGrady,
2012)

Effect of Active and
Passive smoking during
Pregnancy on its
Outcomes
Pregnancy Planning,
Smoking Behaviour
during Pregnancy, and
Neonatal Outcome: UK
Millennium Cohort
Study
Quitting Smoking
During Pregnancy and
Birth Outcomes:
Evidence of Gains
Following Cessation by
Third Trimester
Risk Factors for
Excessive Gestational
Weight Gain in a
Healthy, Nulliparous
Cohort
Smoking and Smoking
Cessation During Early
Pregnancy and its Effect
on Adverse Pregnancy
Outcomes and Fetal
Growth
Impact of Smoking
Exposure Change on
Infant Birth Weight
Among a Cohort of
Women in Prenatal
Smoking Cessation
Study
Infant Birth Outcomes
Among Substance Using
Women: Why Quitting
Smoking During
Pregnancy is Just as
Important as Illicit Drugs

Level of
Evidence
IV cohort study

Summary
Statistically significant lower birth weight and lower apgar
scores of those who smoked.

IV

cohort study

This study grouped those who stopped smoking and those who
reduced number of cigarettes together and was still significant
that it reduced low birth weight and prematurity.

IV

cohort study

There is a significant improvement in weight and head
circumference if quit prior to third trimester.

IV

cohort study

Women gain more weight when stop smoking during
pregnancy which can act as a barrier to smoking cessation.

IV

cohort study

Smoking cessation during early pregnancy significantly
increases birth weight, length, and head circumference.

IV

cohort study

Although not statistically significant, the increase in infant
birth weight associated with reduction from heavy to light
exposure suggests potential for benefit. The only statistically
significant comparison was between quitters and sustained
heavy smokers, confirming that smoking cessation should
remain the goal for pregnant women.

IV

case control

Smoking during pregnancy caused lower birth weight than
illicit drug use.

14

24
E

(Seybold et
al, 2012)

25
E

(Graham,
Flemming,
Fox, Heirs,
& Sowden,
2014)

Smoking in Pregnancy
in West Virginia: Does
Cessation/Reduction
Improve Perinatal
Outcomes?
Cutting Down: Insights
from Qualitative Studies
of Smoking in
Pregnancy

IV

cohort study

Decreasing smoking reduces preterm deliveries

V

SR of
qualitative
research

"Our findings suggest that cutting down in pregnancy, as an aid
and an alternative to quitting require greater recognition of
healthcare and tobacco control policies are to be sensitive to
the perspectives and circumstances of smokers."

Behavioral interventions.
Theories. Two theories and one model were displayed in multiple studies throughout
literature. The theory of planned behavior helps guide intervention development (Ben Natan,
Golubev, & Shamrai, 2010). Using the transtheoretical model to guide intervention was more
likely to assist patients to stop smoking (Aveyard et al, 2006). The model of the 5 A’s was
widely supported throughout literature. ACOG uses this model to guide recommendations for
smoking cessation during pregnancy. The 5 A’s include asking about smoking status, assess
readiness to change, advise the pregnant patient about risks with smoking, assist her to stop
smoking, and arrange follow up. Using the 5 A’s has shown improvement in quit rates during
pregnancy (Kim, England, Kendrick, Dietz, & Callaghan, 2009). However, as discussed above,
usage of the 5 A’s is suboptimal. Because of this, current literature mostly examined how to
increase utilization of the 5 A’s. Having an established office intervention improved the “assist”
stage of the 5A’s (Moss, Cluss, Watt-Morse, & Pike, 2009). Educating providers also improves
utilization of 5A’s (Bowden, Oag, Smith, & Miller, 2010).
Financial incentives. Throughout literature there was a high number of articles
examining financial incentives role and efficacy in smoking cessation during pregnancy.
Financial incentives were found to increase and prolong cessation rates (Ierfino et al, 2015;
Donatell, 2000) They also increase program involvement and program success (Mantzari, Vogt, &
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Marteau, 2012). A voucher system was shown to have improved birth outcomes (Higgins et al,
2010). However, financial incentives had low acceptance rates among pregnant women (Lynagh,
Bonevski, Symonds, & Sanson-Fisher, 2011). This was in part due to beliefs it would create
inequalities, enhance or decrease motivation, and add stress to relationships (Thomson, Morgan,
Crossland, Bauld, Dykes, & Hoddinot, 2014).
Increasing access. Another common theme throughout literature regarding behavioral
interventions for smoking cessation during pregnancy was increasing access to obstetric
providers. This was hypothesized to help because there were many pregnant women who
reported low to moderate awareness of effects of smoking during pregnancy (Levis et al, 2014).
Many different programs were trialed in attempt to address this issue, however minimal success
was documented. Phone calls weekly from the providers’ office did not increase cessation rates
compared to receiving a handout (Bullock, Everett, Mullen, Geden, Longo, & Madsen; 2009).
Motivational interviewing did not increase cessation rates (Hayes et al, 2013). Counseling did
not provide large gains in cessation (Filion et al, 2011). Ultrasound feedback did not increase
quit rates (Stotts et al, 2009). While many attempts were unsuccessful, there were a few
programs able to successfully help pregnant smokers to quit. Community based pregnancy
resource centers were found to successfully educate low income and help with successful
quitting (Cluss, Levine, & Landsittel, 2011). Home visits were found to increase successful quit
rates (Karatay, Kublay, & Emiroğlu, 2010; Fedall et al, 2012; Matone, O'Reilly, Xianqun,
Localio, & Rubin, 2012) Video Doctor access which “delivered interactive tailored messages, an
educational worksheet for participants, and a cuing sheet for providers at next visit” at baseline,
1 month, and each prenatal care visit after one month did increase cessation rates (Tsoh, Kohn, &
Gerbert, 2010).
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Coping mechanisms. There were three main coping mechanisms found to increase
smoking cessation during pregnancy. Yoga helped manage stress while quitting (Bock et al,
2012). Exercise decreased craving and withdrawal symptoms (Harper, Fitzgeorge,Tritter, &
Prapavessis, 2012). Partner support was found to have mixed reviews; two articles found it did
not impact quit rates (Koshy, Mackenzie, Tappin, & Bauld, 2010; Hemsing, Greaves, O'Leary,
Chan, & Okoli, 2012), while another article found it significantly increased quit rates (Donatell,
2000). Table three summarizes the findings of individual research articles in the focus area of
behavioral interventions.
Table 3: Behavioral Interventions
Citation
28
B

Title

Level of
Evidence
VI descriptive

Summary

Smoking During Pregnancy:
Analysis of Influencing
Factors Using the Theory of
Planned Behaviour

29
B

(Ben
Natan,
Golubev, &
Shamrai,
2010)
(Levis et al,
2014)

Women’s Perspectives on
Smoking and Pregnancy and
Graphic Warning Labels

VI

descriptive

30
B

(Stotts et
al, 2009)

Ultrasound Feedback and
Motivational Interviewing
Targeting Smoking Cessation
in the Second and Third
Trimesters of Pregnancy.

II

RCT

31
B

(Aveyard et
al, 2006)

A Randomized Controlled
Trial of Smoking Cessation
for Pregnant Women to Test
the Effect of a
Transtheoretical Model-Based
Intervention on Movement in
Stage and Interaction with
Baseline Stage.

II

RCT

Transtheoretical model based interventions are
statistically more likely to assist patients to stop smoking.

32
B

(Ierfino et
al, 2015)

Financial Incentives for
Smoking Cessation in
Pregnancy: a Single Arm
Intervention Study Assessing
Cessation and Gaming

IV

cohort study

This study found there were higher prolonged cessation
rates with financial incentives

17

Nursing interventions guided by the TPB constructs may
help Israeli women quit smoking during pregnancy and
reduce prevalence of smoking during pregnancy.

Participants had low to moderate awareness of effects of
smoking during pregnancy. Many believed it was okay to
smoke during 1st trimester. Motivations to quit included
risk-focused info especially about risk to baby and
graphic warning labels with pictures.
Ultrasound feedback with smoking effects on baby
yielded no significant difference in quit rates.

33
B

(Tsoh,
Kohn, &
Gerbert,
2010)

Promoting Smoking Cessation
in Pregnancy with Video
Doctor Plus Provider Cueing:
a Randomized trial

II

RCT

The Video Doctor plus provider cueing is an efficacious
adjunct to routine prenatal care by promoting provider
advice and smoking reduction among pregnant smokers.

34
B

(Moss,
Cluss,
WattMorse, &
Pike, 2009)
(Kim,
England,
Kendrick,
Dietz, &
Callaghan,
2009)
(Mantzari,
Vogt, &
Marteau,
2012)

Targeting Pregnant and
Parental smokers: Long-term
Outcomes of a Practice-Based
Intervention

IV

cohort study

Office interventions improved obstetric providers’ rates
of “assist”.

The Contribution of ClinicBased Interventions to Reduce
Prenatal Smoking Prevalence
among US Women

IV

cohort study

5 A's with 5-15 min of provider counseling and a selfhelp handout decreased the smoking prevalence in late
pregnancy from 16.4% to 15.6%

The Effectiveness of Financial
Incentives for Smoking
Cessation During Pregnancy:
is it from Being paid or from
the Extra Aid?
Acute Exercise Effects on
Craving and Withdrawal
Symptoms among Women
Attempting to Quit Smoking
Using Nicotine Replacement
Therapy
Paying Women to Quit
Smoking During Pregnancy?
Acceptability Among
Pregnant Women.

III

controlled
trial without
randomizati
on

Woman receiving incentive for involvement perceive
significantly higher involvement and program success.

IV

case control

An acute bout of moderate intensity exercise can alleviate
cravings as well as psychological and sedation
withdrawal symptoms in quitters using NRT.

VI

descriptive

Acceptability for the use of financial incentives in
reducing antenatal smoking is low among pregnant
women.

Baby BEEP: a Randomized
Controlled Trial of Nurses'
Individualized Social Support
for Poor Rural Pregnant
Smokers.

II

RCT

No significant difference between women who received
weekly phone calls and those who received pamphlets

Unintended Consequences of
Incentive Provision for
Behavior Change and
Maintenance around
Childbirth

VI

descriptive

"Financial incentives are controversial and generated
emotive and oppositional responses." "Four key themes
emerged: how incentives can address or create
inequalities; enhance or diminish intrinsic motivation and
wellbeing; have a positive or negative effect on
relationships"

Financial Incentives for
Smoking Cessation in
Pregnancy: RCT
An Integrated Brief
Intervention to Address
Smoking in Pregnancy

II

RCT

Significantly more women who received financial
incentives stopped smoking.

IV

cohort

Educating providers about 5A's and how to utilize
increases their rate of 5A utiliation

35
B

36
B

37
B

(Harper,
Fitzgeorge,
Tritter, &
Prapavessis
, 2012)

38
B

(Lynagh,
Bonevski,
Symonds,
& SansonFisher,
2011)
(Bullock,
Everett,
Mullen,
Geden,
Longo, &
Madsen;
2009)
(Thomson,
Morgan,
Crossland,
Bauld,
Dykes, &
Hoddinot,
2014)
(Tappin et
al, 2015)

39
B

40
B

41
B
42
B

(Bowden,
Oag,
Smith, &
Miller,
2010)

18

43
B

(Filion et
al, 2011)

The effect of Smoking
Cessation Counselling in
Pregnant Women: a MetaAnalysis of Randomized
Controlled Trials.

I

SR of RCT

“Available data from RCTs examining the isolated effect
of smoking cessation counseling in pregnant woman are
limited but sufficient to rule out large treatment effects.
Future RCTs should examine pharmacological therapies
in this population."

44
B

Smoking Cessation During
Pregnancy: the Influence of
Partners, Family and Friends
on Quitters and Non-Quitters

VI
I

qualitative

Close associates such as partners and support people vary
in their support for the smoking woman attempting to
quit. Future research needs to evaluate their role further.

Partner Support for Smoking
Cessation During Pregnancy: a
Systematic Review

I

SR of RCT

Partner support was not found to have a significant
impact on pregnant smoker quit rates.

46
B

(Koshy,
Mackenzie,
Tappin, &
Bauld,
2010)
(Hemsing,
Greaves,
O'Leary,
Chan, &
Okoli,
2012)
(Higgins et
al, 2010)

II

RCT

These results provide evidence that smoking-cessation
treatment with voucher-based CM may improve
important birth outcomes.

47
B

(Bock et al,
2012)

II

RCT

At 8 weeks, more women had stopped smoking in yoga
group. It is thought to be because of stress control.

48
B

(Hayes et
al, 2013)

IV

cohort

No significant difference between those who received
motivational interviewing and those who did not.

49
B

(Chang et
al, 2013)

VI

qualitative

5A's: 98% of providers asked, 21% performed at least
the first three A's, no providers did all 5

50
B

(Naughton,
Prevost,
Gilbert, &
Sutton,
2012)

II

RCT

MiQuit intervention group received a tailored handout
and 11 week program of tailored text messages.
Significantly more women stopped smoking in the
control group and significantly more women had
cognitive determinants to quit in the future.

51
B

(Windsor et
al, 2014)

III

case control

SCRIPT program included home visits and was
significantly more likely to quit.

52
B

(Naughton,
Jamison, &
Sutton,
2013)

Effects of Smoking Cessation
with Voucher-Based
Contingency Management on
Birth Outcomes
Yoga as a Complementary
Treatment for Smoking
Cessation in Women
Effectiveness of Motivational
Interviewing in Influencing
Smoking Cessation in
Pregnant and Post-partum
Disadvantaged Women
Smoking Is Bad for Babies:
Obstetric Care Providers' Use
of Best Practice Smoking
Cessation Counseling
Techniques
Randomized Controlled Trial
Evaluation of a Tailored
Leaflet and SMS Text
Message Self-help
Intervention for Pregnant
Smokers (MiQuit)
Effectiveness of the Smoking
Cessation and Reduction in
Pregnancy Treatment
(SCRIPT) Dissemination
Project: A Science to Prenatal
Care Practice Partnership.
Attitudes Towards SMS text
Message Smoking Cessation
Support: a Qualitative Study
of Pregnant Smokers

VI

qualitative

Text messaging helped most when it was personalized
and convenient real-time intervention.

53
B

(Hill et al,
2013)

Baby Be Smoke Free:
Teenage Smoking Cessation
Pilot.

IV

cohort study

Technology may be best way to help pregnant teens stop
smoking because they prefer to keep their smoking status
a secret (stage of development?)

45
B

19

54
B

(Bombard
et al, 2013)

Telephone Smoking Cessation
Quitline Use Among Pregnant
and Non-pregnant Women

IV

cohort study

Quitlines improved cessation rates.

55
B

(Baxter,
EversonHock,
Messina,
Guillaume,
Burrows, &
Goyder;
2010)
(Cluss,
Levine, &
Landsittel,
2011)

Factors Relating to the Uptake
of Interventions for Smoking
Cessation among Pregnant
Women: A Systematic Review
and Qualitative Synthesis.

I

SR of
qualitative
and
quantitative
literature

"The review suggests a need for greater training in this
area and the greater use of protocols. (p 685)"

The Pittsburgh STOP
Program: Disseminating an
Evidence-Informed
Intervention for Low-Income
Pregnant Smokers.
The SUCCESS Program for
Smoking Cessation for
Pregnant Women

IV

cohort study

Community based pregnancy resource centers can
successfully educate low income pregnant smokers on
smoking risks during pregnancy. This can lead to
smoking cessation.

IV

cohort study

Setting Universal Cessation Counseling Education and
Screening Standards (SUCCESS) was developed as an
evidence-based practice program which established a
protocol for office use with intervention guides and
successful increased quit rates.

Short-Term Behavioral
Changes in Pregnant Women
after a Quit-Smoking Program
via E-Learning
Effect of motivational
interviewing on smoking
cessation in pregnant women

IV

case control

E-learning program using cell phone internet connection
to give support and advise to pregnant smokers
successfully increased quit rates.

IV

case control

This is an example of a successful stop smoking program
which included 8 home visits, 5 interventions based of
transtheoretical model, and 3 follow up appointments.

Integrating a Clinical Model
of Smoking Cessation into
Antenatal Care.
Smoking Prevalence and
Smoking Cessation Services
for Pregnant Women in
Scotland
Randomized Controlled Trial
Using Social Support and
Financial Incentives for High
Risk Pregnant Smokers:
Significant Other Support
(SOS) Program
Home Visitation Program
Effectiveness and the
Influence of Community
Behavioral Norms: a
Propensity Score Matched
Analysis of Prenatal Smoking
Cessation

IV

cohort study

Midwife home visits and enlisting in formal smoking
cessation program increased quit rates.

IV

cohort study

The US problem of poorly implemented plan is
happening in other countries too (Scotland).

II

RCT

Monetary incentive and personal support person
significantly increased quit rates.

IV

cohort study

Home visits increased rates of smoking cessation.

56
B

57
B

60
B

(Albrecht,
KellyThomas,
Osborne, &
Ogbagabar,
2011)
(Fujioka,
Kobayashi
& Turale,
2012)
(Karatay,
Kublay, &
Emiroğlu,
2010)
(Fedall et
al, 2012)

61
B

(Tappin et
al, 2010)

62
B

(Donatell,
2000)

63
B

(Matone,
O'Reilly,
Xianqun,
Localio, &
Rubin,
2012)

58
B

59
B
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Nicotine replacement therapy. The United States Food and Drug Administration (FDA)
has determined nicotine replacement therapy (NRT) to be category D (Nicotin, 2015). Because
of this, providers within the United States do not generally prescribe NRT. However, European
countries have approved NRT’s use in pregnancy; effectiveness and consequences of NRT have
been extensively studied. Throughout literature, NRT has been found to decrease nicotine
cravings and decrease fetal exposure to nicotine (Oncken, Campbell, Chan, Hatsukami, &
Kransler, 2009). NRT has also been found to decrease low birth weight compared to smokers
(Oncken & Kranzler, 2009; Lancaster, 2014; Forinash, Pitlick, Clark, & Alstat, 2010) and when
studied there was no difference compared to active smokers (Coleman, Chamberlain, Davey,
Cooper, & Leonardi-Bee, 2012). NRT also decreased prematurity compared to smokers
(Forinash, Pitlick, Clark, & Alstat, 2010), and there was no difference compared to non-smokers
(Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2012). However, both of these results
are only true if the mother stops smoking with NRT use. One study found that if the mother uses
NRT and continues to smoke the risk of preterm delivery and small for gestational age double
compared to non-smokers, whereas those who smoke without NRT use is only 1.31 times more
likely to experience these effects as non-smokers (Gaither, Brunner Huber, Thompson, & HuetHudson; 2009). There were three studies that evaluated NRT’s correlation with birth defects. All
three studies found that NRT did not cause birth defects (Oncken & Kranzler, 2009; Coleman et
al, 2012; Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2012). However, of the five
studies that evaluated NRT usage and quit rates, none of the five studies found a significant
difference in quit rates when NRT was used at standard dosing (standard dosing means the same
dosing used on non-pregnant adults). It is hypothesized that this is because maternal nicotine
absorption decreases since some of the nicotine is transferred to the fetus. If this is true,
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increased doses of nicotine replacement may lead to higher cessation rates. However, high dose
NRT has not been studied for efficacy or safety profile. Table four summarizes the findings of
individual research articles focusing on NRT.
Table 4: NRT
64
N

65
N

66
N

67
N
68
N

69
N

(Coleman,
Chamberlai
Cooper, &
LeonardiBee, 2011)
(Coleman
et al, 2014)

(Gaither,
Brunner
Huber,
Thompson,
& HuetHudson;
2009)
(Strandberg
-Larsen et
al, 2008)
(Brose,
McEwen,
& West,
2013)
(ElMohandes,
2013)

70
N

(Oncken &
Kranzler,
2009)

71
N

(Lancaster,
2014)

72
N

(Coleman
et al, 2012)

73
N

(Forinash,
Pitlick,
Clark, &

Efficacy and Safety of
Nicotine Replacement Therapy
for Smoking Cessation in
Pregnancy: Systematic Review
and Meta-Analysis
The SNAP Trial: A
Randomized PlaceboControlled Trial of Nicotine
Replacement Therapy in
Pregnancy -- Clinical
Effectiveness and Safety Until
2 years After Delivery, with
Economic Evaluation
Does the Use of Nicotine
Replacement Therapy During
Pregnancy Affect Pregnancy
Outcomes?

I

SR of
RCT

No statistical significance that NRT is any more or less safe
nor is it more or less effective than standard practice.

II

RCT

NRT use at standard dosing yielded no significant
difference in smoking cessation rates. 2-year-olds born to
women who used NRT were more likely to have survived
without any developmental impairment. More research
needed to evaluate higher doses

I
V

cohort
study

Women who use NRT and continue to smoke are at twice
the risk of preterm delivery and small for gestational age as
non-smokers. Those who smoke without NRT use are 1.31
times more likely to deliver early and have babies small for
gestational age. Thus, if NRT is used, the women must stop
smoking.

Use of Nicotine Replacement
Therapy During Pregnancy and
Stillbirth: A Cohort Study
Association Between Nicotine
Replacement Therapy Use in
Pregnancy and Smoking
Cessation
A Randomized Clinical Trial
of Trans-Dermal Nicotine
Replacement in Pregnant
African-American Smokers.
What do We Know about the
Role of Pharmacotherapy for
Smoking Cessation Before or
During Pregnancy?

I
V

cohort
study

NRT not associated with still births. Smoking during
pregnancy has higher rate of still births.

I
V

cohort
study

"Combination NRT was associated with higher odds of
quitting compared with no medication, whereas single NRT
showed no benefit."

II

RCT

No significant difference between those who received NRT
and cognitive behavioral therapy (CBT) and those who
received CBT alone.

I

SR RCT

NRT does not improve quit rates, but does increase birth
weight and did not adversely affect birth outcomes.

In Pregnant Smokers, the
Nicotine Patch did not Increase
Abstinence or Birthweight
More than Placebo.
A Randomized Trial of
Nicotine-Replacement Therapy
Patches in Pregnancy
Nicotine Replacement Therapy
Effect on Pregnancy Outcomes

II

RCT

In pregnant women who smoked, the 16-hour nicotine
patch did not increase smoking abstinence or infant
birthweight more than placebo.

II

RCT

I

SR

No significant difference in smoking cessation or birth
defects between those who received NRT patches and the
control group.
NRT use significantly decreased the risk of preterm
delivery and low birth weight compared to that of smokers.

Alstat, 2010)
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74
N

75
N

76
N

(Dornelas,
Oncken,
Greene,
Sankey, &
Kranzler,
2013)
(Oncken,
Campbell,
Chan,
Hatsukami,
& Kransler,
2009)
(Coleman,
Chamberlai
n, Davey,
Cooper, &
LeonardiBee, 2012)

Major Depression and PTSD
in Pregnant Smokers Enrolled
in Nicotine Gum Treatment
Trial.

II

RCT

"Pregnant women with a history of MDD and PTSD appear
to be as likely to benefit from smoking cessation treatment
as those without such a history."

Effects of Nicotine Patch or
Nasal Spray on Nicotine and
Cotinine Concentrations in
Pregnant Smokers.

II

RCT

Daily, cigarette craving decreased more in the patch verses
other groups. Nicotine patch and nasal spray reduce
maternal nicotine exposure compared with smoking and
may be effective for smoking cessation.

Pharmacological Interventions
for Promoting Smoking
Cessation during Pregnancy

I

SR of
RCT

This SR found no studies examining buproprion or
varenicline. No statistically significant difference was seen
for smoking cessation in later pregnancy after using NRT as
compared to control. There were no statistically significant
differences in rates of miscarriage, stillbirth, premature
birth, birthweight, low birthweight, admissions to neonatal
intensive care or neonatal death between NRT or control
groups.

Medications. Outside of NRT there are two main pharmacologic therapies offered to
non-pregnant adults that have been documented throughout literature as effective for smoking
cessation assistance. Bupropion and varenicline are relied on extensively to successful assist
smokers to stop smoking. However, neither of these medications are approved by the FDA for
use in pregnancy. Very few studies have evaluated their safety and effectiveness.
Bupropion. Bupropion was originally developed for depression. It works to inhibit
uptake of norepinephrine and dopamine by the neurons (Bupropion hydrochloride, 2015). Its
mechanism of action for smoking cessation assistance is unknown, but is used widely within the
United States and is approved by the FDA. However, it is pregnancy category C (Bupropion
hydrochloride, 2015). One study evaluated Bupropion’s effects on the fetus (Chun-Fai-Chan et
al, 2005). It found that no major malformations occurred. Babies were delivered at normal
gestational age and normal birth weights (Chun-Fai-Chan et al, 2005). However, spontaneous
abortions increased (20 spontaneous abortions in 136 live births). A study looking at bupropion
effects on placentas after birth observed that bupropion did in fact cross the placenta, but
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appeared to not impair placental functioning (Earhart, Patrikeeva, Wang, Reda Abdelrahman,
Hankins, Ahmed, & Nanovskaya, 2010).
Varenicline. The other drug widely used by non-pregnant smokers wishing to stop
smoking is varenicline which works by both agonizing and blocking nicotine receptors
(Varenicline, 2015). There is only one observational study of a mother who used varenicline for
four weeks while pregnant. Her baby was born at 38 weeks with no abnormalities (Kaplan,
Dündar, Kasap, & Karadas; 2014). Even though varenicline has hardly been studied, it is
estimated that one percent of women are exposed to varenicline during pregnancy accidentally.
Because of this, Harrison-Woolrych, Paterson, and Tan, (2013), call for a registry of women
exposed to varenicline during pregnancy to track drug efficacy and pregnancy outcomes. Table
five outlines the articles covering medications for smoking cessation during pregnancy.
Table 5: Medications
79
M

(ChunFai-Chan
et al,
2005).

80
M

(HarrisonWoolrych,
Paterson,
& Tan,
2013)
(Kaplan,
Dündar,
Kasap, &
Karadas;
2014)
(Earhart,
Patrikeeva
, Wang,
Reda
Abdelrah
man,
Hankins,
Ahmed, &
Nanovska
ya, 2010)

81
M

82
M

Pregnancy Outcome of
Women Exposed to
Bupropion during
Pregnancy: A Perspective
Comparative Study
Exposure to the Smoking
Cessation Medicine
Varenicline During
Pregnancy: A Prospective
Nationwide Cohort Study
Pregnancy Outcome after
Varenicline Exposure in the
First Trimester

I

SR of
RCT

Transplacental Transfer and
Metabolism of Bupropion

IV case
control

IV cohort
study

VI case
I
report
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Bupropion exposure during pregnancy did not
increase preterm delivery, small for gestational age, or
malformations. It raised the rates of spontaneous
abortion. Rates of spontaneous abortions are similar to
the safety of antidepressants during pregnancy."
Approximately 1% of women of reproductive age
prescribed varenicline may be exposed to this
medicine during pregnancy. “This could result in
significant fetal exposure worldwide and indicates the
need for a global pregnancy register for varenicline.”
Mother used varenicline for 4 weeks and baby was
born at 38 weeks with no anomalies.

Bupropion crosses the placenta, however does not
affect placental functioning. These data suggest that
bupropion has the potential of being used for smoking
cessation during pregnancy and should be further
investigated for its safety and efficacy.

Recommendations
Four key recommendations with four sub-recommendations emerged from reviewed
literature. Table six summarizes these recommendations. NRT therapy at standard doses did not
yield cessation improvements. However, since nicotine crosses the placenta, a smaller percent is
available to the mother. Therefore further research needs to evaluate higher doses of NRT for
safety and efficacy. A varenicline registrar could benefit the progression of research in
understanding the safety and efficacy of varenicline. Monetary incentives were the most
effective non-pharmacologic intervention. This could be utilized by insurance companies to
incentivize women to stop smoking while pregnant.
Table 6: Recommendations
Recommendation
1) Future research
studying high dose
NRT
2) Establish a
varenicline registrar

Strength
Strong

3) Monetary incentives

Strong

4) Development and
utilization of clinic
based practice
protocols

Strong

4. a) Use the 5 A’s to
the full extent

Moderate

4. b) Target preconception visits
4. c) Recognize cutting
down as 2nd line

Moderate

4. d) Cessation before
3rd trimester

Weak

Strong

Moderate

Corresponding Studies and Level of Evidence
43 (Filion et al, 2011)
65 (Coleman et al, 2014)
75 (Oncken, Campbell, Chan, Hatsukami, & Kransler, 2009)
43 (Filion et al, 2011)
80 (Harrison-Woolrych, Paterson, & Tan, 2013)
81 (Kaplan, Dündar, Kasap, & Karadas; 2014)
41 (Tappin et al, 2015)
46 (Higgins et al, 2010)
62 (Donatelle, 2000)
39 (Bullock, Everett, Mullen, Geden, Longo, & Madsen; 2009)
55 (Baxter, Everson-Hock, Messina, Guillaume, Burrows, & Goyder;
2010)
57 (Albrecht, Kelly-Thomas, Osborne, & Ogbagabar, 2011)
59 (Karatay, Kublay, & Emiroğlu, 2010)
61 (Tappin et al, 2010)
33 (Tsoh, Kohn, & Gerbert, 2010)
34 (Moss, Cluss, Watt-Morse, & Pike, 2009)
35 (Kim, England, Kendrick, Dietz, & Callaghan, 2009)
42 (Bowden, Oag, Smith, & Miller, 2010)
49 (Chang et al, 2013)
76 (Coleman, Chamberlain, Davey, Cooper, & Leonardi-Bee, 2012)
23
24
25
19

(Bailey, McCook, Hodge, & McGrady, 2012)
(Seybold et al, 2012)
(Graham, Flemming, Fox, Heirs, & Sowden, 2014)
(Bailey, McCook, Clements, & McGrady, 2011)
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I
II
II
I
IV
VII
II
II
II
II
I
IV
IV
IV
II
IV
IV
IV
VI
I
IV
IV
V
IV

Evidence based practice protocol. In order to address the need for established protocols
and interventions, an evidence based practice protocol was developed for implementation at an
obstetric office in Southwest Ohio. This protocol uses the 5 A’s and starts with asking every
gynecologic patient, regardless of pregnancy status, if they smoke. This allows for providers to
target pre-conception patients for smoking cessation (recommendation 4b) From this question,
providers follow the protocol algorithm (image 1) which leads to a provider hand out (image 2)
which prompts the provider regarding what to discuss and key points to highlight. The protocol
also utilizes a patient hand out (image 3). This handout is to be sent home with the pregnant
smoking patient at every visit as a reminder of the goal and provides tips when they are no longer
at the providers’ office. Both the provider hand out and patient hand out highlight
recommendations 4c and 4d.
Chapter 5: Discussion
After a thorough search of the literature, there was no clearly effective and safe option for
smoking cessation during pregnancy. Home visits were consistently effective at increasing
smoking cessation rates, however, most of these studies utilized the Midwife system set up in
Europe. Home visits may not be feasible in the current US healthcare system. Incentives such as
monetary or voucher systems showed success. One drawback to these is perceived stress on
relationships and emotional status that women reported (Thomson, Morgan, Crossland, Bauld,
Dykes, & Hoddinott, 2014). Utilization of the 5A’s framework leads to increased cessation rates
if fully utilized. At this time, no pharmacologic options including NRT, Bupropion, and
varenicline have been found both safe and effective. For these reasons it is best to target smoking
women before they are pregnant in order to attain highest smoke free pregnancy rates. As the
protocol shows, pre-family planning visits are key visits for providers to emphasize that stopping
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smoking is a must prior to pregnancy. At this stage, medications can be used safely with greater
efficacy. If a woman is already pregnant and still smoking the priority should be to stop before
reaching the third trimester. Complete cessation of smoking early in pregnancy is the gold
standard and best goal. However, for woman who cannot stop, decreasing nicotine exposure
should be recognized as second line. The goal of cutting down on cigarettes early in pregnancy is
to ultimately stop smoking by the third trimester. However, even if smoking is never completely
stopped, research has shown that cutting down improves fetal outcomes. To continue addressing
this problem, more clinics need to implement evidence based practice protocols.
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Figure 1: Evidence Based Practice Protocol
Based off of the 5A’s:

1) Ask: Is the patient smoking?

1)
2)
3)
4)
5)

Yes
No

Ask
Advise
Assess
Assist
Arrange

Is the patient pregnant?
Good job! Stay
smoke free!

Yes

No

3rd Trimester

Planning to
conceive?

1st or 2nd Trimester
No

2) Provider hand out
3) Assess patient
readiness
4) Patient hand out 4,
offer pharmacologic
intervention
5) Follow up yearly

Yes
Goal: smoke free by 28 weeks
2) Provider hand out
3)Listen to patient questions and
concerns, discuss barriers and
coping mechanisms.
4) Set goal and formal plan
together, give patient hand out 2
5) Follow up in 1 month

Goal: smoke free prior to conception
2) Provider hand out
3) Assess patient readiness
4) Aggressively manage smoking cessation with
lifestyle and pharmacologic intervention
5) Follow up at next regularly scheduled visit
and PRN with questions

Goal: stop smoking ASAP!
2) Provider hand out
3) Listen to questions and concerns, discuss
barriers and coping mechanism.
4) Set goal and formal plan, give patient hand
28 out 1
5) Follow up in 2 week

Figure 2: Provider Handout

What to Tell Your Patients About
Smoking and Pregnancy
Complications during Pregnancy
Smoking during pregnancy can cause intrauterine growth
restriction leading to small for gestational age. It can also
cause pre-term delivery.

Complications after Delivery
Smoking during pregnancy can cause your baby to have
more apnea episodes immediately after delivery, can
cause asthma as a child and into adulthood, and can
decrease growth from delivery through puberty.

Goals of Quitting
Quitting before the third trimester significantly decreases
damage to the placenta and fetus. No nicotine during
pregnancy is the goal, but cutting down can also reduce
the damage to placenta and fetus. Before the third
trimester, discuss importance of 100% cessation prior to
28 weeks. If in 3rd trimester stress importance of
minimizing exposure starting now!

Coping Mechanisms
Stress/emotions and habit are two of the hardest parts of
stopping smoking. Remove cigarettes and ash trays from
view. Remove triggers and stay away from situations that
make you want to smoke. Think through relaxation
techniques that you can use as coping mechanisms. Many
find benefit from yoga, exercise, and talking with
supportive people in your life.

Resources for Quitting:
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ACOG: A Clinician’s Guide to Helping
Pregnant Women Quit Smoking
http://www.acog.org/-/media/Departments/Tobacco-Alcohol-and-Substance-Abuse/SCDP.pdf?

Figure 3: Patient Handout

Stopping Smoking can Help Your Baby be Healthy!
Smoking during pregnancy can cause
preterm delivery, decreased weight and
size, new born apnea episodes,
childhood asthma, and many other
complications.

Coping Mechanisms
Coping mechanisms can make your
stopping smoking journey a little easier
Yoga, Exercise, Talking with a close friend
or partner, Getting outside, message.

Ready to Quit?
These tips can help!
1)
2)
3)
4)
5)

Make a plan
Tell family and friends your plan
Plan for challenges and prepare coping skills
Remove and avoid triggers
Talk to your obstetric provider

Resources to help you stay smoke free: smokefree.gov,
women.smokefree.gov and the smoke free women app, 1800-QUIT-NOW
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